GM

UPCOMING EVENT

General
Meeting
DATES
February 6-9, 2023
LOCATION
Hollywood, Florida

This is the preeminent genome science and technology conference for top global researchers, leaders and innovators.

Francis

GENERAL MEETING PREVIOUS SPEAKER

Francis
Collins
WORK
National Institutes of Health (NIH)

Two decades of breathtaking progress in genomics – but the best is yet to come

Dr Marco

GENERAL MEETING PREVIOUS SPEAKER

Dr. Marco
Marra
WORK
Michael Smith Genome Sciences Centre

Towards a Canadian national program for genomic profiling of treatment resistant cancers

Elodie

GENERAL MEETING PREVIOUS SPEAKER

Elodie
Ghedin
WORK
New York University

Characterizing influenza virus diversity within and across infected hosts, and the interactions of microbes in the respiratory tract, to better understand the dynamics of viral transmission

Richard M Myers

GENERAL MEETING PREVIOUS SPEAKER

Richard
M. Myers
WORK
HudsonAlpha Institute for Biotechnology

How allelic variation and gene expression changes contribute to human traits, including diseases, behaviors and other phenotypes

Luis Diaz

GENERAL MEETING PREVIOUS SPEAKER

Luis
Diaz
WORK
Johns Hopkins Hospital

Clinical development of tumor-derived DNA as a biomarker for cancer screening, early detection, monitoring and measurement of early residual disease.

Elaine Mardis

GENERAL MEETING PREVIOUS SPEAKER

Elaine
Mardis
WORK
Nationwide Children's Hospital

Co-Executive Director of the institute for Genomic Medicine at Nationwide Children's Hospital and the Nationwide Foundation: Endowed Chair of Genomic Medicine

previous arrow
next arrow

SAVE THE DATE
AGBT GM 24: February 5–8, 2024 | AGBT GM 25: February 23–26, 2025

ABOUT

The General Meeting is AGBT’s flagship event for bringing together global leaders, researchers, and innovators.

Advances in Genome Biology and Technology (AGBT) delivers a premier experience where heads of labs, institutions, businesses, financial analysts and other high-level stakeholders come together to advance the field and drive game-changing innovation. Significant scientific advances are announced and showcased, science and industry forge enduring partnerships, and significant investments and notable acquisitions are made.

The meeting format includes daytime plenary sessions that feature invited speakers and abstract-selected talks that highlight cutting-edge research across the broad landscape of genomics. The evening concurrent session includes experimental and computational approaches for effectively utilizing the latest DNA sequencing technologies.

1,055

Attendees

151

Universities and Governments

162

Companies

70

CEOS, CMOS, and CSOS

Graphic shows: 2022 In-Person Demographics

2023 FEATURED SPEAKERS

Jill Banfield

Professor at University of California, Berkeley Jill Banfield is a Professor in the Departments of Earth and Planetary Science and Environmental Science, Policy, and Management (see contact information below). She also has an appointment in the geochemistry group at Lawrence Berkeley National Laboratory. Her primary research interests are in geomicrobiology and environmental microbiology. Her group
READ FULL BIO

Alex Cagan

Researcher at Wellcome Sanger Institute Alex Cagan investigates evolutionary processes in somatic tissue. His research focuses on characterising mutation and selection in healthy tissues and how this relates to cancer and ageing. Evolution is often considered to be an almost imperceptibly slow process. However, the cells that compose our own bodies are constantly acquiring mutations.
READ FULL BIO

Love Dalen

Professor at Centre for Palaeogenetics, Stockholm, University Love Dalen's general research interests are focused on the use of DNA technology to investigate the ecology and evolution of different species, and how past environmental changes have determined the distribution and abundance of organisms. Read More
READ FULL BIO

Dame Sue Hill 

Chief Scientific Officer at NHS England Professor Dame Sue Hill OBE PhD DSC CBiol FRSB Hon FRCP Hon FRCPath is the Chief Scientific Officer for England – providing expert clinical scientific advice across the health system and head of profession for the healthcare science workforce in the NHS and associated bodies – embracing more than
READ FULL BIO

Carolyn Hogg

Population Biologist at The University of Sydney Carolyn has been working on the conservation of threatened species for over twenty-five years both in Australia and overseas. She is currently the Senior Research Manager for the Australasian Wildlife Genomics Group in the Faculty of Science. She has been working with the Save the Tasmanian Devil Program
READ FULL BIO

Duncan MacCannell

Chief Science Officer at Centers for Disease Control and Prevention/ Office of Advanced Molecular Detection Duncan MacCannell is the chief science officer for the CDC’s Office of Advanced Molecular Detection (OAMD), where he helps coordinate the implementation and support of pathogen genomics, bioinformatics, high-performance computing and other innovative laboratory technologies across the CDC’s four infectious
READ FULL BIO

Judith Mank

Professor and Lab Director at The University of British Columbia Judith Mark uses evolutionary, genomic, and population genetic tools to ask fundamental questions related to how selection acts on males and females within a species, and how the genome responds to contradictory selection to encode sexually dimorphic traits. Read More
READ FULL BIO

Alicia Martin

Assistant Investigator at Analytic and Translational Genetics Unit at Mass General Research Institute and Harvard Medical School Alicia R. Martin, Ph.D., is an Instructor in Investigation at the Analytic & Translational Genetics Unit at Massachusetts General Hospital, an Instructor in Medicine at Harvard Medical School, and an Associated Scientist at the Broad Institute affiliated with the Stanley Center
READ FULL BIO

Karen Miga

Assistant Professor at UC Santa Cruz Karen Miga, assistant professor of biomolecular engineering at UC Santa Cruz, was named one of the 100 most influential people of 2022 by TIME. The honor was announced on May 23. Miga and her colleagues, Adam Phillippy, Evan Eichler, and Michael Schatz, led an international team of scientists — the
READ FULL BIO

Freda Miller

Deputy Director and Professor at The University of British Columbia Dr. Miller joins UBC from the Hospital for Sick Children in Toronto, where she was a Senior Scientist and Professor at the University of Toronto. She is a Fellow of the Royal Society of Canada and of the American Association for the Advancement of Science
READ FULL BIO

Benedict Paten

Associate Professor at University of California, Santa Cruz Dr. Benedict Paten is an associate professor in the Department of Biomolecular Engineering at the University of California Santa Cruz (UCSC) and an associate director of the UC Santa Cruz Genomics Institute. He oversees the Computational Genomics Lab and Computational Genomics Platform groups at UCSC, which together
READ FULL BIO

Pardis Sabeti

Professor at Broad Institute of MIT and Harvard Dr. Sabeti’s lab focuses on developing new analytical and genomic methods to study evolutionary adaptation and genetic diversity in humans and pathogens, with three current research foci: (1) Identifying and characterizing the underlying adaptive changes that have shaped the human species over time; and (2) Investigating genetic
READ FULL BIO

Winston Timp

Associate Professor of Biomedical Engineering at Johns Hoplins University Winston Timp, an associate professor of biomedical engineering, focuses on the development and application of sequencing technologies to gain a deeper understanding of biology and a more accurate set of clinical tools for human disease. He holds joint appointments in the Department of Molecular Biology and
READ FULL BIO

2023 SPONSORS

Gold Sponsor

Silver Sponsors

Bronze Sponsors

Element Biosciences logo, black

ORGANIZING COMMITTEE

Penelope Bonnen

As an Associate Professor at Baylor College of Medicine, Dr. Bonnen is applying her acumen in bioinformatics and human genetics to gene discovery studies for an array of phenotypes and diseases including disorders caused by mitochondrial dysfunction and cancer. The Bonnen lab develops and applies methods for analyzing next-generation sequence data and interpretation of human

READ FULL BIO

Kimberly Doheny

Dr. Kimberly Doheny is an Associate Professor of Genetic Medicine and Pathology at the Johns Hopkins University School of Medicine.  She is Director of the Center for Inherited Disease Research, Co-Director of Johns Hopkins Genomics, Co-Director of the Kennedy Krieger Institute Intellectual Developmental Disabilities Research Center Genomics Core and Director of the Laboratory Genetics and

READ FULL BIO

Stacey Gabriel

Institute Scientist and Senior Director of the Genomics Platform, Broad Institute of MIT and Harvard Stacey Gabriel is Senior Director of the Genomics Platform at Broad Institute, and has led platform development, execution and operation since the Institute’s founding. She is also Chair of Professional Scientists and serves on the Institute’s Executive Leadership Team. Gabriel

READ FULL BIO

Eric D. Green

Dr. Eric Green is the Director of the National Human Genome Research Institute (NHGRI) at the U.S. National Institutes of Health (NIH). He is the third NHGRI Director, having been appointed by NIH Director Dr. Francis Collins in 2009. Dr. Green has been at the Institute for more than 25 years, during which he has

READ FULL BIO

Martin Hirst

Dr. Hirst is a Senior Scientist and Head of Epigenomics at Canada’s Michael Smith Genome Sciences Centre at BC Cancer, Associate Professor in the Department of Microbiology and Immunology and Associate Director of the Michael Smith Laboratory at the University of British Columbia (UBC). His research focuses on understanding epigenetic dysfunction in cancer and his laboratory

READ FULL BIO

Christopher E. Mason

Dr. Christopher Mason is a Professor of Genomics, Physiology, and Biophysics at Weill Cornell Medicine and the Director of the WorldQuant Initiative for Quantitative Prediction. He is also co-Founder and global director at Biotia, co-Founder and scientific director at Onegevity, Director of Genomics at Tempus Labs, and recently published The Next 500 Years: Engineering Life

READ FULL BIO

John D. McPherson

Dr. McPherson is the Deputy Director of the UCD Comprehensive Cancer Center and Professor, Department of Biochemistry and Molecular Medicine. He has deep expertise in DNA sequencing and cancer genomics through his involvement in the Human Genome Project and large-scale tumor sequencing as a founding member of the International Cancer Genome Consortium. Within the ICGC,

READ FULL BIO

Stephen B. Montgomery

Stephen Montgomery’s laboratory at Stanford University studies genetic effects on gene regulation and gene expression to identify the molecular and cellular mechanisms which define human traits. They focus on understanding the effects of genome variation on cellular phenotypes and cellular modeling of disease through genomic approaches such as next generation RNA sequencing in combination with

READ FULL BIO

Federica Di Palma

Federica Di Palma, is a Professor at the University of East Anglia in the United Kingdom and the Founder and Director of Science is Global strategy and consulting. She is passionate about exploring and preserving Biodiversity around the world. She leads a number of multidisciplinary research programmes which use genomics approaches to understand how evolutionary

READ FULL BIO

Len Pennacchio

Dr. Len Pennacchio is a Senior Scientist at the Lawrence Berkeley Laboratory (LBL), Deputy Director of the DOE Joint Genome Institute, and Adjunct Professor at the University of California Berkeley.  He received his PhD in Genetics from Stanford University in 1998 under Rick Myers and then served as a DOE Alexander Hollaender Distinguished Fellow at

READ FULL BIO

Beth Shapiro

Beth Shapiro is an evolutionary biologist who specializes in the genetics of ice age animals and plants. As Professor of Ecology and Evolutionary Biology at UC Santa Cruz and HHMI Investigator, Beth uses DNA recovered from bones and other remains to study how species evolved through time and how human activities have affected and continue

READ FULL BIO

Michael Zody

Dr. Michael Zody is a computational biologist with over 15 years of experience writing bioinformatic software, analyzing genomic and transcriptomic sequence data, and managing engineers and researchers. He serves as the Scientific Director of Computational Biology at the New York Genome Center. He started his career at the Whitehead Institute Center for Genome Research (now

READ FULL BIO

Testimonials

AGBT is always the most important meeting I attend all year. The cutting edge scientific talks and the networking makes tremendous opportunities possible.

2019 AGBT Attendee

As it was my first time, I now know why AGBT is considered the best genomics meeting in the world…Every aspect of the conference was a highlight. Getting a cross-section of the current trends, the talks, the vendors,  the networking…everything.

2019 AGBT Attendee

I loved speaking to vendors and learning more about their new tech and how it could be applied to my lab…So many engaging talks and new connections.

2019 AGBT Attendee